Cathie Wood’s ARK Invest Buys Over 4.1 Million Shares of This Biotech-Focused SPAC

One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 4.1 million shares of Soaring Eagle Acquisition Corp. (NASDAQ: SRNG) on Wednesday, as the share price of this fund traded up less than 1% in the day’s session. The fund’s share price has greatly improved over the past year.

Specifically, ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 4,144,190 shares of the special purpose acquisition company (SPAC). At Wednesday’s closing price, this would have valued this purchase at roughly $41 million. This is only a small fraction of the total holdings. This fund is up 50% over the past 52 weeks.

Here is a quick look at all the purchases made by ARK ETFs:

FundTickerCompanyShares
ARKGBEAMBeam Therapeutics17,964
ARKGSGFYSignify Health484,603
ARKGSMFRSema4179,239
ARKGNVTAInvitae25,000
ARKGSRNGSoaring Eagle Acquisition4,144,190
ARKGMASS908 Devices2,401
ARKGFATEFate Therapeutics82,289
ARKGCRSPCRISPR Therapeutics12,743
ARKGZYZymergen2,469,102
ARKGRPTXRepare Therapeutics7,962
ARKKVCYTVeracyte5,000
ARKKPATHUiPath324,106
ARKKFATEFATE Therapeutics30,751
ARKKEDITEditas Medicine14,844
ARKQMKFGMarkforged435,263
ARKQKTOSKratos Defense & Security Solutions284,321
ARKQAVAVAerovironment22,724
ARKWPDPagerDuty30,000
ARKWLPSNLivePerson251,511
ARKWVUZIVuzix25,000

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.

ALSO READ: Stock Market Due for Big Sell-Off: 5 Safe Dividend Stocks to Move to Now


Get Our Free Investment Newsletter

I have read, and agree to the Terms of Use

Source: Read Full Article